Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ironwood Pharmaceuticals Inc shares valued at $7,745 were sold by MCCOURT Thomas A on May 16 ’25. At $0.58 per share, MCCOURT Thomas A sold 13,353 shares. The insider’s holdings dropped to 1,147,281 shares worth approximately $0.71 million following the completion of this transaction.
Also, Gaskins Tammi L sold 2,563 shares, netting a total of over 1,487 in proceeds. Following the sale of shares at $0.58 each, the insider now holds 242,596 shares.
Before that, MCCOURT Thomas A had added 14,661 shares to its account. In a trade valued at $8,650, the Officer bought Ironwood Pharmaceuticals Inc shares for $0.59 each.
As published in a research note from Wells Fargo on April 15, 2025, Ironwood Pharmaceuticals Inc [IRWD] has been rated down from an Overweight to an Equal weight. Analysts at Jefferies downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in mid April. As of April 14, 2025, Citizens JMP has decreased its “Mkt outperform” rating to a “Mkt perform” for IRWD. Earlier on September 09, 2024, Leerink Partners initiated its rating. Their recommendation was “a Market perform” for IRWD stock.
Analyzing IRWD Stock Performance
During the last five days, there has been a surge of approximately 4.32%. Over the course of the year, Ironwood Pharmaceuticals Inc shares have dropped approximately -86.00%. Shares of the company reached a 52-week high of $4.7750 on 01/07/25 and a 52-week low of $0.5271 on 05/16/25.
Support And Resistance Levels for Ironwood Pharmaceuticals Inc (IRWD)
According to the 24-hour chart, there is a support level at 0.5854, which, if violated, would cause prices to drop to 0.5506. In the upper region, resistance lies at 0.6395. The next price resistance is at 0.6588. RSI (Relative Strength Index) is 34.64 on the 14-day chart, showing neutral technical sentiment.
